| D |
Report |
Operating (non-GAAP) EPS – Q2 2026 |
BEAT |
pred ~$0.80 vs. cons $0.78 |
MEDIUM |
| D |
Report |
GAAP/Reported EPS – Q2 2026 |
MISS |
pred ~$0.68 vs. cons $0.74 |
MEDIUM |
| D |
Report |
Total Operating Revenue – Q2 2026 |
IN-LINE |
pred ~$4.08B vs. cons $4.06B |
MEDIUM |
| D |
Guide |
FY2026 Operating EPS guidance (midpoint) |
UNCHANGED |
guide ~$3.57 vs. cons $3.57 (FY2026; range $3.45-$3.69 reaffirmed) |
HIGH |
| D |
Guide |
CVOW total project budget/in-service schedule |
UNCHANGED |
guide ~$11.4B vs. cons $11.4B (FY2026-2027; majority of turbines in service by YE2026, balance by mid-2027) |
MEDIUM |
| D |
Guide |
NEE merger closing timeline / special shareholder meetings |
UNCHANGED |
guide ~2027H2 vs. cons 2027H2 (deal close target; special meetings early Sept 2026 reaffirmed) |
HIGH |
| D |
Guide |
FFO-to-debt credit metric |
UNCHANGED |
guide ~15%+ vs. cons 15% (FY2026 target; above Moody's/S&P downgrade threshold) |
MEDIUM |
| D |
Return |
Day-1 residual (stock − beta × S&P 500) |
+0.3% |
— |
LOW |
| D |
Return |
5-day cumulative residual |
+0.2% (STABILIZE) |
D's post-announcement beta to SPX is near zero/negative (-0.23) while correlation to NEE is 0.91 — the stock now trades as a fixed-ratio merger-arb instrument (~3% discount to implied deal value of ~$72) rather than on standalone fundamentals. A modest operating-EPS beat with FY26 guidance, CVOW budget/schedule and merger-timeline (Sept 2026 votes, H2 2027 close) all reaffirmed removes incremental deal-risk but doesn't re-rate the arb spread, since the exchange ratio is fixed; a possible GAAP-EPS miss (Zacks ESP -5.4%, estimates cut ~10% over 60 days, likely merger transaction/financing costs) could spook headline-driven flows on day 1, but with no new regulatory information the spread should stabilize near its pre-print level within a few sessions rather than trending further, as forward EPS revisions get netted against Dominion's already-embedded 'certainty equivalent' merger valuation. |
LOW |